1. Home
  2. ACR vs ARCT Comparison

ACR vs ARCT Comparison

Compare ACR & ARCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ACR

ACRES Commercial Realty Corp.

HOLD

Current Price

$20.01

Market Cap

169.2M

Sector

Real Estate

ML Signal

HOLD

Logo Arcturus Therapeutics Holdings Inc.

ARCT

Arcturus Therapeutics Holdings Inc.

HOLD

Current Price

$6.87

Market Cap

194.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACR
ARCT
Founded
2005
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
169.2M
194.1M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
ACR
ARCT
Price
$20.01
$6.87
Analyst Decision
Buy
Buy
Analyst Count
2
11
Target Price
$24.50
$38.44
AVG Volume (30 Days)
43.9K
627.7K
Earning Date
10-29-2025
11-10-2025
Dividend Yield
N/A
N/A
EPS Growth
14.65
N/A
EPS
0.95
N/A
Revenue
$88,952,000.00
$97,601,000.00
Revenue This Year
$4.05
N/A
Revenue Next Year
$0.38
N/A
P/E Ratio
$21.10
N/A
Revenue Growth
14.87
N/A
52 Week Low
$15.64
$5.85
52 Week High
$24.61
$24.17

Technical Indicators

Market Signals
Indicator
ACR
ARCT
Relative Strength Index (RSI) 28.77 47.68
Support Level $23.48 $6.02
Resistance Level $21.89 $6.75
Average True Range (ATR) 0.74 0.30
MACD -0.39 0.16
Stochastic Oscillator 3.62 69.87

Price Performance

Historical Comparison
ACR
ARCT

About ACR ACRES Commercial Realty Corp.

ACRES Commercial Realty Corp is a commercial real estate investment trust that focuses on originating, holding and managing commercial real estate (CRE) mortgage loans and equity investments in commercial real estate properties through direct ownership and joint ventures. The company invests in commercial real-estate-related assets, including whole loans, A notes, B notes, mezzanine loans, and mortgage-related securities, as well as commercial finance assets, which include other asset-backed securities, senior secured corporate loans, equipment leases and notes, trust preferred securities, debt tranches of collateralize debt obligations, and private equity investments mainly issued by financial institutions.

About ARCT Arcturus Therapeutics Holdings Inc.

Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases. It operates in one business segment, which includes all activities related to the discovery, development, and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC and LUNAR-CF. Its Vaccine candidates include LUNAR-FLU, KOSTAIVE XBB.1.5, KOSTAIVE, and Others.

Share on Social Networks: